Use of ketamine in the treatment of cachexia
US11400060B2 · kind B2 · utility
0Cited by
2References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 19, 2020 |
| Grant date | Aug 2, 2022 |
| Priority date | — |
| Expiry date | Nov 19, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0019
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein is an use of ketamine in the treatment of cachexia, wherein the ketamine is administered to a subject who is treated with 5-FU and the dose amount of ketamine is about 60% to 5-FU. Specifically, the ketamine in the present invention is used to elevate the survival rate and improve the reduction of weight caused by cachexia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.